A25 Pill - white oval, 15mm
Pill with imprint A25 is White, Oval and has been identified as Erythromycin Delayed Release 250 mg. It is supplied by Torrent Pharmaceuticals Limited.
Erythromycin is used in the treatment of Bronchitis; Bowel Preparation; Bacterial Endocarditis Prevention; Bartonellosis; Bullous Pemphigoid and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A25
Erythromycin Delayed Release
- Imprint
- A25
- Strength
- 250 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Macrolides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Torrent Pharmaceuticals Limited
- Manufacturer
- Appco Pharma LLC
- National Drug Code (NDC)
- 13668-0586
- Inactive Ingredients
-
calcium silicate,
silicon dioxide,
croscarmellose sodium,
hydroxypropyl cellulose,
hypromellose 2208 (100 mPa.s),
magnesium stearate,
mannitol,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
poloxamer 407,
polyethylene glycol,
corn starch,
sodium bicarbonate,
sodium citrate,
sodium lauryl sulfate,
talc,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "A25"
More about erythromycin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (67)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: macrolides
- Breastfeeding
- En español
Patient resources
Other brands
Erythrocin, Ery-Tab, EryPed, E.E.S. Granules, ... +4 more
Professional resources
- Erythromycin monograph
- Erythromycin Ethylsuccinate (AHFS Monograph)
- Erythromycin Lactobionate (AHFS Monograph)
- Erythromycin Stearate (AHFS Monograph)
- Erythromycins General Statement (AHFS Monograph)
Other brands
Erythrocin, Ery-Tab, EryPed, E.E.S. Granules, PCE Dispertab
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.